David Windley
Stock Analyst at Jefferies
(3.64)
# 795
Out of 5,072 analysts
197
Total ratings
67.26%
Success rate
14.47%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Buy | $317 → $409 | $329.77 | +24.03% | 27 | Oct 17, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $400 → $450 | $594.28 | -24.28% | 6 | Sep 9, 2025 | |
| IQV IQVIA Holdings | Upgrades: Buy | $195 → $225 | $230.01 | -2.18% | 5 | Sep 9, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $220 → $175 | $185.00 | -5.41% | 15 | Sep 9, 2025 | |
| FTRE Fortrea Holdings | Maintains: Hold | $7 → $9.5 | $12.72 | -25.31% | 3 | Sep 9, 2025 | |
| CRL Charles River Laboratories International | Upgrades: Buy | $142 → $195 | $178.14 | +9.46% | 20 | Sep 9, 2025 | |
| STE STERIS | Initiates: Hold | $263 | $266.28 | -1.23% | 1 | May 29, 2025 | |
| SLQT SelectQuote | Initiates: Hold | $2.75 | $1.45 | +89.66% | 1 | May 21, 2025 | |
| CNC Centene | Maintains: Hold | $64 → $61 | $39.34 | +55.06% | 28 | Apr 29, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $17.97 | -33.22% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $419 → $253 | $245.77 | +2.94% | 18 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $402 → $422 | $277.28 | +52.19% | 17 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $354 → $297 | $148.26 | +100.32% | 23 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $12 → $3.75 | $0.93 | +305.14% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $338.26 | +78.56% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $573.48 | -34.61% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $17.51 | -11.48% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $240.29 | +12.36% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $9.16 | +69.21% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $277.25 | +93.33% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $23.36 | +24.14% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $7.59 | +3,167.46% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.34 | - | 5 | Oct 9, 2017 |
UnitedHealth Group
Oct 17, 2025
Maintains: Buy
Price Target: $317 → $409
Current: $329.77
Upside: +24.03%
Medpace Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $400 → $450
Current: $594.28
Upside: -24.28%
IQVIA Holdings
Sep 9, 2025
Upgrades: Buy
Price Target: $195 → $225
Current: $230.01
Upside: -2.18%
ICON Public Limited Company
Sep 9, 2025
Downgrades: Hold
Price Target: $220 → $175
Current: $185.00
Upside: -5.41%
Fortrea Holdings
Sep 9, 2025
Maintains: Hold
Price Target: $7 → $9.5
Current: $12.72
Upside: -25.31%
Charles River Laboratories International
Sep 9, 2025
Upgrades: Buy
Price Target: $142 → $195
Current: $178.14
Upside: +9.46%
STERIS
May 29, 2025
Initiates: Hold
Price Target: $263
Current: $266.28
Upside: -1.23%
SelectQuote
May 21, 2025
Initiates: Hold
Price Target: $2.75
Current: $1.45
Upside: +89.66%
Centene
Apr 29, 2025
Maintains: Hold
Price Target: $64 → $61
Current: $39.34
Upside: +55.06%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $17.97
Upside: -33.22%
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $245.77
Upside: +2.94%
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $277.28
Upside: +52.19%
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $148.26
Upside: +100.32%
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $0.93
Upside: +305.14%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $338.26
Upside: +78.56%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $573.48
Upside: -34.61%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $17.51
Upside: -11.48%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $240.29
Upside: +12.36%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $9.16
Upside: +69.21%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $277.25
Upside: +93.33%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $23.36
Upside: +24.14%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $7.59
Upside: +3,167.46%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.34
Upside: -